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1. Introduction
René Descartes (1596-1650) in the published Discourse on Method, wrote: “…And because
the actions of life often brook no delay, it is certainly very true that, when it is not in our
power to determine the truest opinions, we ought to follow the most probable ones, and
even when we see no difference in probability among this group of truths or that one, never‐
theless, we have to decide on some for ourselves and then to consider them, not as some‐
thing doubtful with regard to the practical matter at hand, but as manifestly true and very
certain, because the reason which made us choose them has these qualities”. [1] Colonosco‐
py (COL) issues this doubt.
Everybody known the effect of COL on colorectal cancer (CRC) until 2009, when an observa‐
tional case–control study did not identify a reasonable explanation for COL: much less effec‐
tive in preventing death from colorectal cancer (CRC) of the right colon compared with the
left colon [2]. Moreover to prevent one cancer death, 1,250 colonoscopies need to be per‐
formed, but perforation of the colon occurs at a rate of about 1 in 1000 procedures [3].
Since polyps often take 10 to 15 years to transform into cancer, in someone at average risk of
colorectal cancer, guidelines recommend 10 years after a normal screening COL before the
next COL. [4,5]. By removing premalignant adenomas and detecting early cancer, COL
should lower colorectal cancer mortality. Although gastroenterologists strongly believe that
© 2013 Vannelli et al.; licensee InTech. This is an open access article distributed under the terms of the
Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits
unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
COL lowers colorectal cancer mortality, evidence in support of this belief is indirect. Robert
S. Sandler in 2010 wrote: “The mortality from colorectal cancer has actually been decreasing
steadily since 1980, long before widespread use of COL or any other screening, and before
use of effective adjuvant therapy for cancer” [6].
However the high cost of biological therapy for advanced CRC, and the high risk of CRC in
low-income population are likely to affect the cost-effectiveness of COL in the future [7,8].
In  Italy  CRC rank  third  for  incidence  among male  (second among female)  and  second
among the most frequent causes of tumour death for both men and women [9]. The cur‐
rent  trend  of  the  incidence  shows  a  slow-down  among  male  patients  and  stabilization
among women. Mortality seems to be in decrease in particular in the population under
50 years old. In Southern Italy and in the Italian islands the incidence is lower (like mor‐
tality), but its trend is less favourable than in central-northern Italy. In the Southern Italy
trends on the increase are reported both among men and women. The success of Color‐
ectal  cancer  screening  (CCS)  is  the  success  of  COL.  However  there  are  critical  points:
complications  of  COL programmes;  low coverage;  low compliance;  overload  on  endos‐
copy facilities.  Faecal  occult  blood screening (FOBT)  for  CRC in  men and women aged
50 to 74 is the Italian and European Union recommendation [10]. CCS is widely accepted
as a public  health policy in Italy [11].  On the contrary few regions have adopted wide‐
spread CCS programmes, although some are inching their way to that goal [12]. The rea‐
son,  is  the  burden  that  extensive  CCS  places  on  COL  services  [13].  Behind  every  CCS
test,  no matter what kind, is  the potential  need for a COL, who can detect and remove
adenomas, and detect asymptomatic cancers [14-19].
The social and economical impact of CRC is such, to warrant the decisions of the Italian gov‐
ernment to implement the screening as a form of prevention. According to the Italian gov‐
ernment agreements, on September 30th 2010, the Italian Regions should have implemented
the Plan of National Prevention and transformed it into Plan of Regional Prevention: April
24th 2010 agreement between Government, Regions and Autonomous Provinces of Trento
and Bolzano: “… the regions are committed to implement by September 30, 2010, the Re‐
gional Plan of Prevention to carry out the interventions established by the National Plan of
Prevention …” [20].
Two authorities coordinate activities and research projects for both general and specific,
population. The Italian Network of Cancer Registries (AIRTUM), and the National Centre
for Disease Prevention and Control (Ccm) [21,22].
AIRTUM, called AIRT until  2006, was born in 1997, in 2005, AIRTUM created a central‐
ized database where data from Cancer Registries are stored and, after checked for quali‐
ty and completeness, used for collaborative studies on cancer epidemiology in Italy [14].
Cancer registration in Italy began in the 1970s with a steady increase in experiences and
coverage  of  an  increasing  proportion  of  the  Italian  resident  population.  The  density  of
registries is greater in northern Italy, especially in the North-east, compared with Central
and Southern Italy (Figure 1).
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Figure 1. Italian Network of Cancer Registries: red actived, white not yet actived.
On the other hand, especially in the South of Italy, cancer registration has remarkably ex‐
panded in recent years with several new registries, which provide a more detailed and de‐
scriptive dataset of the oncologic illnesses in this area of Italy. Figure 1 shows the proportion
of the resident population covered by cancer registries according to region and geographic
macroareas (Northwest, Northeast, Centre, and South). Regional coverage varies from 0% in
several southern regions (Puglia, Basilicata, Abruzzi, Molise), as well as Val d’Aosta, to
100% (e.g., Umbria, Friuli Venetia Giulia, Trento, and Bolzano). Nevertheless, Southern Italy
reported an increase in cancer reporting. Today more than a third of the Italian population
lives in an area with an active cancer registry. This proportion differs between areas (37% in
the Northwest, 68% in the Northeast, 26% in the Centre, and 18% in South). Overall, AIR‐
TUM Registries involve more than 19.000.000 subjects, or 34% of the entire Italian resident
population. The importance of AIRTUM, is supported by the growing number of accredited
registries contributing to the centralized dataset, thus improving representation at the na‐
tional level. Furthermore, the presence of historic registries, operating since the 1980s, has
helped calculate 20-year incidence trends, and stable, robust prevalence estimates. Ccm is to
liaise between the Ministry of health on the one side, and regional governments on the other
as regards surveillance, prevention and promptly responding to emergencies [23-25]. Over
the years, Ccm has acquired a specific identity, which makes it unique within the frame‐
work of Italian public health; its main features are: analyze health hazards implementation
in prevention secondary and tertiary prevention. The Centre is a bridge between the world
of research and health facilities on the one hand, and the best practices and entities being
developed on the other, by activating institutional partnerships and professional collabora‐
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tions: its aim is to build an Italian prevention network. The goal of Ccm is to optimise the
national prevention Plan checking surveillance plans and active prevention with the Re‐
gions.(Figure 2).
Figure 2. Regional colorectal cancer screening: red actived, white not yet actived, red and white partial actived.
The cooperation with these two authorities introduced design standards and evaluation cri‐
teria, as part of an active collaboration relationship between AIRTUM, CCM and the part‐
ners with which it has agreements, both in the design and monitoring phase of programmes
and projects of CCS.
At the present days, no studies are ongoing to define the cause-effect relationship between
costs, CCS programme, and COL.
In this paper we show how both the choice of specific constraints on output weights (CCS
programme) can affect the measurement of COL efficiency using the "Data Envelopment
Analysis" (DEA).
In their originating study, Charnes, Cooper, and Rhodes on 1978, described DEA as a
“mathematical programming model applied to observational data [that] provides a new
way of obtaining empirical estimates of relations - such as the production functions and/or
efficient production possibility surfaces – that are cornerstones of modern economics” [27].
DEA is a relatively new “data oriented” approach for evaluating the performance of a set of
peer entities called Decision Making Units (DMUs) which convert multiple inputs into mul‐
tiple outputs.
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DEA is applied by the management control to evaluate the relative efficiency of human re‐
sources, the results are related to the cost of diagnostic procedures, standardized by the
case-mix, and both scatter plot and cluster analysis are produced to find out related area of
performance and to plan a strategy for the continuous quality improvement. The objective
of this study therefore, is to propose one model of study of the costs in the strategy of CCS
supporting the benefits of COL using DEA model.
2. Materials and methods
The absence in the literature of previous experience or analogous models can makes difficult
to create a logistic model. At the present days, there are many studies to define the cause-
effect relationship between costs, and CCS programme, or between costs and COL. The ob‐
jective of this study is to propose one model of study of the costs in the strategy of CCS
supporting the benefits of COL using DEA model. Since the incidence of colorectal cancer
shows a geographical variability, we considered the epidemiological data in the light of the
different Italian cancer records, which are often referred to provincial or regional results and
we compared them with the screening tests available in each Region.
In the first part of the paper, we calculated the global population in Italy and the number of
current colorectal cancer cases using the historical archive of ISTAT (Italian National Insti‐
tute of Statistics). The ISTAT produces and distributes information that describes the social,
economic and environmental conditions of the Country, and the changes taking place with‐
in it, in strict compliance with legal provisions on confidentiality. As the main producer of
national statistics, it provides data and releases information to European statistical authori‐
ties and international organizations. We then evaluated the economical impact considering
every single available regional result obtained from the archives of Age.Na.S. (Italian Agen‐
cies for Regional Health Care Services), AIRTUM, and CCM, and comparing them with the
available Italian data obtained from the Italian Ministry of Health and the statistical registers
of INAIL (Italian institute for insurance against industrial accident) and INPS (Italian Insti‐
tute of social insurance). The Age.Na.S. is a public agency founded in 1993. In the Italian
healthcare service the Agency plays as a technical body supporting the Ministry of Labour,
Health and Social Services and Regions. The Agency also coordinates health research pro‐
grams financed by the Ministry of Labour, Health and Social Services or by the Regions. The
National Fund against Accidents created on 1883, took the name of INAIL on 1933. INAIL
took up the management of compulsory insurance against occupational diseases in the in‐
dustrial and agricultural sector, diseases caused by X-rays and radioactive substances; com‐
pulsory insurance has also been extended to "housewives". It produces and distributes
information on occupational diseases. The INPS, established in 1933, is the large Italian pub‐
lic body that pays out old-age pensions to workers, after receiving contributions from them
throughout their working lives, and manages the types of assistance provided for by the
“social state”, sickness, maternity and unemployment benefits, invalidity payments and so‐
cial payments for citizens who are in need. INPS is one of the biggest public body in Europe,
produces and distributes information that describes National Health Service.
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In view of the geography of the Italian territory and the distribution of the population we
analyzed the data considering three macro-areas which include different regions, i.e. the re‐
gions of Northern Italy: Piedmont, Emilia Romagna, Liguria, Friuli Venetia Giulia, Veneto,
Trenton Alto-Adige, Lombardy and Valle d’Aosta; the regions of Central Italy: Tuscany,
Umbria, Latium, Marche, Abruzzi, Molise and Sardinia; the regions of Southern Italy: Cam‐
pania, Puglia, Basilicata, Calabria and Sicily.
For each Region we considered the following indicators in order to assess a possible plan of
screening campaign of colorectal cancers: global population, mean age and population older
than 65 years; relationship between Gross Domestic Product (GDP) and per capita income;
incidence of colorectal cancer and possible screening campaign on the territory; index of pa‐
tients’ emigration and reimbursement through Diagnostic Related Group (DRG) of the path‐
ology as a ratio versus the unit value represented by Italy as a system.
The second part of the paper is the object of the article: the implement of particular method‐
ologies in order to determine which COL is cost-effective in the mass CCS programme. In
this chapter a method for efficiency measurement in CCS programme has been described.
First an overview of efficiency measurements applicable is given. Calculation methods is de‐
scribed and examples of inputs and outputs are provided.
A method to measure efficiency is proposed. This method proves to be particularly suc‐
cessful  in  cost-efficiency  analysis,  when  the  performance  indicators  are  numerous  and
hard  to  aggregate.  The  results  show  that  there  are  two  cost-effective  strategies  after  a
positive FOBT: COL.
We performed an explorative study to efficiency measurement in CCS. To construct an effi‐
ciency measure or measures for the CCS programme, literature has been searched for differ‐
ent types of efficiency measures used in healthcare. Hence a selection of criteria and
methods is made which tend to be suitable to evaluate which COL is cost-effective in the
mass CCS programme.
Besides Italian CCS programme were carried out to gain understanding of the care process
for CRC patients. The proper knowledge of the process it is useful to choose suitable per‐
formance indicators.
3. Results
Out of a population of 60.387.000 inhabitants (data updated at 2010), the incidence of color‐
ectal cancers was almost of 49.000 cases, with a prevalence of over 310.000 cases and mortali‐
ty higher than 18.000 cases (data updated at 2006). The analysis of the abovementioned three
macro-areas is characterized by strong differences both in general and in particular terms.
There are considerable imbalances between the Northern, Central and Southern areas con‐
sidering their input, output and outcome.
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Data in terms of distribution of population, mean age and population older than 65 years
are distributed in the different macro-areas according to the distribution recorded by the
Italian Institute of Statistics which depicts particular realities partially due to the industrial
development and the local health level. We can differentiate in detail the following data for
each Region (see Tables 1-3).
Population
(pop)
Mean
age
% pop ≥
65
years
GDP/
capita
index
Incidence
colorectal
cancer
Screening plans Migration
Index
DRG
Index
Piedmont 4.432.571 44,9 22,6 1,09 90,79
64,11
4 plans
sigmoidoscopy
8,43 1,01
Emilia Romagna 4.337.979 45,0 22,8 1,21 139,58
82,86
11 plans
(100% territory)
6,31 1,06
Liguria 1.615.064 47,3 26,7 1,03 104,16
82,5
1 plan 11,19 1
Friuli-Venetia
Giulia
1.230.936 45,4 22,7 1,11 140,17
95,52
Global regional plan 6,4 1,22
Veneto 4.885.548 42,9 19,3 1,15 124,02
83,94
17 plans 5,31 1,17
Trenton Alto-
Adige
1.018.657 41,3 17,8 1,25 113,60
76,14
Global regional plan
TRENTO
10,56 1
Lombardy 9.742.676 43,0 19,6 1,30 107,93
74,5
15 plans
(100% territory)
3,9 0,81
Valle d’Aosta 127.065 43,6 20,3 1,32 82,83
60,04
Global regional plan 22,17 1
ITALY 60.387.000 42,8 19,9 1 107,8
69,64
L.D. 138 2004 art. 2
bis
Sof > 50 years
- - 1
Table 1. Macro-area: Northern Italy
Piedmont is a Region with a large-size population with mean age and rate of elderly popula‐
tion higher than the Italian average. It has at its disposal a bit more resources than the Italian
average and its screening campaign covers only some provinces; the incidence of the disease
is lower than the Italian average; the emigration index is low and the refund of the health
expenditure is a little bit higher than the national average. Emilia Romagna is a large-size
population with mean age and rate of elderly persons higher than the Italian average. It has
at its disposal more resources than the national average and its screening campaign covers
all the provinces, the incidence of the disease is higher than the Italian average; the emigra‐
tion index is low and the refund of the health expenditure is a little bit higher than the na‐
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tional average. Liguria has a middle-size population with mean age and rate of elderly
definitely higher than the Italian average. It has at its disposal a little bit more resources than
the Italian average and its screening campaign covers only one province; the incidence of
the disease is lower than the National average; its emigration index is high and the refund of
the health expenditure is on the average. Friuli Venetia Giulia Region has a middle-size pop‐
ulation with mean age and rate of elderly persons higher than the Italian average. It has at
its disposal more resources than the Italian average and its screening campaign covers all
the provinces with a regional plan; the incidence of the disease is higher than the national
average; its emigration index is low and the refund of the health expenditure is higher than
the national average.
Veneto Region has a large-size population with mean age and rate of elderly in line with
the Italian average. It  has at its disposal more resources than the Italian average and its
screening campaign covers all  the provinces;  the incidence of  the disease is  higher than
the national  average,  its  emigration index is  low and the refund of  the health expendi‐
ture  is  higher  than  the  national  average.  Trenton  Alto  Adige  Region  has  a  middle-size
population with mean age and rate of elderly persons lower than the Italian average. It
has at its disposal more resources than the national average and its screening campaign
covers the whole region,  the incidence of  the disease is  higher than the Italian average;
its emigration index is high and the refund of the health expenditure is in line with the
national  average.  Lombardy has a  large-size  population with mean age higher  than the
average and a rate of elderly slightly lower than the Italian average. It has at its disposal
more resources than the national average and its screening campaign covers all its prov‐
inces, the incidence of the disease is slightly higher than the Italian average, it has a low
emigration index and the refund of  health expenditure  is  lower than the national  aver‐
age. Valle d’Aosta Region has a small-size population with mean age and rate of elderly
persons higher than the national  average.  It  has at  its  disposal  more resources than the
national  average,  its  screening campaign covers  the  whole  Region,  the  incidence  of  the
disease is lower than the national average; it has a high emigration index and the refund
of health expenditure is in line with the national average.
Tuscany Region has a large-size population with mean age and rate of elderly persons high‐
er than the Italian average. It has at its disposal more resources than the Italian average and
its screening campaign covers the whole territory; the incidence of the disease is lower than
the national average; its emigration index is mean and the refund of health expenditure is
lower than the national average. Umbria Region has a small-size population with mean age
and a rate of elderly persons higher than the Italian average. It has at its disposal fewer re‐
sources than the Italian average and its screening campaign covers the whole Region; the in‐
cidence of the disease is higher than the national average; the emigration index is high and
the refund of health expenditure is higher than the national average.
Lazio Region has a large-size population with mean age and a rate of elderly persons lower
than the Italian average. It has at its disposal more resources than the Italian average and its
screening campaign covers only some provinces; the incidence of the disease is lower than
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the national average; its emigration index is intermediate and the refund of health expendi‐
ture is lower than the national average.
Population
(pop)
Mean
age
% pop ≥
65
years
GDP/
capita
index
Incidence
colorectal
cancer
Screening plans Migration
Index
DRG
Index
Tuscany 3.707.818 4,3 23,3 1,09 106,5
61,01
12 plans
(100% territory)
5,92 0,79
Umbria 894.222 44,9 23,3 0,95 123,73
78,80
4 plans
(100% territory)
11,28 1,72
Lazio 5.626.710 42,6 19,2 1,22 89,06
52,57
4 plans 6,64 0,89
Marche 1.569.578 44,3 22,6 1,00 109,89
67,70
2007 pilot project 10,75 1
Abruzzi 1.334.675 43,4 21,3 0,81 113,25
42,75
6 plans 10,2 1
Molise 320.795 43,6 22,0 0,72 113,29
43,16
Global Regional plan 20,62 1
Sardinia 1.671.001 42,2 17,8 0,80 101,42
54,12
1 plan 4,24 1
ITALY 60.387.000 42,8 19,9 1 107,8
69,64
L.D. 138 2004 art. 2
bis Sof > 50 years
- - 1
Table 2. Macro-area: Central Italy
Marche Region has a middle-size population with mean age and rate of elderly persons
higher than the Italian average. It has at its disposal resources in line with the national aver‐
age and implements no screening campaign; the incidence of the disease is higher than the
national average; its emigration index is high and the refund of health expenditure is in line
with the national average.
Abruzzi has a middle-size population with mean age and rate of elderly persons higher than
the Italian average. It has at its disposal fewer resources than the national average and its
screening campaign covers only some provinces; the incidence of the disease is higher than
the national average; its emigration index is high and the refund of health expenditure is in
line with the national average.
Molise Region has a small-size population with mean age and rate of elderly higher than the
Italian average. It has at its disposal fewer resources than the national average and its
screening campaign covers the whole Region; its emigration index is high and the refund of
health expenditure is in line with the national average.
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Sardinia Region has a middle-size population with mean age and rate of elderly lower than
the Italian average. It has at its disposal resources in line with the national average and its
screening campaign covers only one province; the incidence of the disease is lower than the
national average, its emigration index is low and the refund of health expenditure is in line
with the national average.
Population
(pop)
Mean
age
% pop ≥
65
years
GDP/
capita
index
Incidence
colorectal
cancer
Screening plans Migration
Index
DRG
Index
Campania 5.812.962 39,0 15,4 0,64 60,09
41,07
4 plans 7,55 0,89
Puglia 4.079.702 40,7 17,4 0,66 68,89
35,98
- - 7,64 1
Basilicata 590.601 42,1 20,0 0,70 104,31
35,98
Global regional plan
STOP 2007
24,01 1
Calabria 2.008.709 41,1 18,4 0,65 83,08
35,93
4 plans 14,82 1
Sicily 5.037,799 40,7 18,0 0,66 71,15
45,33
- - 6,09 1
ITALY 60.387.000 42,8 19,9 1 107,8
69,64
L.D. 138 2004 art. 2
bis Sof > 50 years
- - 1
Table 3. Macro-area: Southern Italy
Campania Region has a large-size population with mean age and rate of elderly lower than
the Italian average. It has at its disposal fewer resources than the national average and its
screening campaign covers only some provinces; the incidence of the disease is lower than
the national average; its emigration index is intermediate and the refund of health expendi‐
ture is slightly lower than the national average.
Puglia Region has a large population with mean age and rate of elderly lower than the Ital‐
ian average. It has at is disposal fewer resources than the national average and it has no
screening campaign; the incidence of the disease is lower than the national average and its
emigration index is intermediate. The refund of health expenditure is in line with the nation‐
al average.
Basilicata has a small-sized population with mean age and rate of elderly higher than the
Italian average. It has at its disposal fewer resources than the national average and the
screening campaign was discontinued in 2007, the incidence of the disease is lower than the
national average, its emigration index is high and the refund of health expenditure is in line
with the national average.
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Calabria has a middle-sized population with mean age and rate of elderly lower than the
Italian average. It has at its disposal fewer resources than the national average and its
screening campaign covers only some provinces; the incidence of the disease in lower than
the national average; its emigration index is high and the refund of health expenditure is in
line with the national average.
Sicily has a large population with mean age and rate of elderly lower than the Italian aver‐
age. It has at its disposal fewer resources than the national average and has no screening
campaign; the incidence of the disease is lower than the national average, its emigration in‐
dex is intermediate and the refund of health expenditure is in line with the national average.
4. Discussion
The average cost of colo-rectal cancer treatments in Italy has been estimated to be approxi‐
mately € 9.149,00 per patient per year including chemotherapy [27]. Some authors estimate
that for the city of Ferrara the overall cost related to the introduction of a CCS programme
was approximately € 1.400.000,00 (from October 2005 until March 2007 with more than
99.000 individuals invited) with a large proportion of these costs related to the implementa‐
tion and management of the programme [28]. FOBT plus COL, increase cost relative to
cheapest strategy. As a consequence of screening, some individuals with low risk receive a
recommendation for a follow-up COL. However follow-up colonoscopies will increase the
cost consequences of introducing screening, but not the expected colorectal cancer treatment
costs. The Italian Observatory on screening Practices has been collecting data on CCS since
2004 [29]. In 2007 there were 71 CRC screening programmes in Italy, covering 46,6% of the
total eligible population, with a higher coverage in the North (71,6%), and in the Centre
(52,1%) than in the South (7%). The majority of programmes (65) used the guaiac FOBT
(gFOBT) as first-line test. Only seven programmes used the flexible sigmoidoscopy (FS), of
which three used a combination of FS and gFOBT. The quality and efficacy of the screening
programmes are evaluated using ad hoc indicators developed by the Italian Group for Col‐
orectal Screening (GISCoR) [28]. In 2007, on average 79,1% of the eligible population was in‐
vited for FOBT screening, with only Lombardy, Umbria, and most of the programmes in
Emilia Romagna reaching the 90% target. Among the invited individuals, 46,3% underwent
FOBT with significant variations across (from 26,5% in Lazio to 65% in Veneto) and within
regions (from 11 to 80%). Among the people invited for the first time, the average percent‐
age of individuals with a positive test was 5,6%, while among people who were recalled it
was 4%. The probability of having a positive result was higher for men than for women and
increased with age. Among people with a positive test, only 78,7% underwent a COL [2].
The South and Centre had a lower rate of COL attendance than the North. Men were slight‐
ly more likely to undertake a COL after a positive FOBT than women, mainly because of the
uncomfortable feeling and concern of women having a male physician performing the tests.
The risk of bowel perforation and bleeding during COL was negligible. For FS, on average
66,5% of the eligible population was invited with large variations across programmes. Only
27,7% of those invited underwent FS with a slightly higher proportion among men than
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women. The response rate was higher whenever FS was combined with FOBT [30]. The per‐
centage of FS successfully completed was 88%, with again a higher level among men than
women; 14,3% of men and 7,6% of women were sent for a COL for further analysis and 90%
of these attended the test. In 2007 overall FOBT and FS detected 20.796 adenoma of which,
2.449 were carcinomas. An additional 295 carcinomas were diagnosed in individuals who
underwent further follow-up tests. Most of the adenomas identified were in Stage I, (54.5%),
followed by increased widely Stages III and IV (24,9%), and then in Stage II (20,7%). The crit‐
ical points are: complications of COL (40 programs) with average perforation rate of 0,08%
(2,5% operative COL) and average bleeding rate of 0,55%; low coverage and delay in South‐
ern Italy; low compliance; overload on endoscopy facilities.
The role of screening is an extremely topical question even though in the past it was already
subject of discussion and until few years ago it was considered to fall within the competence
of the central government [31]. Only in the last years we have observed a different interest
especially in Italy due to the changed political conditions. Does a convergence really exist
between federalism, screening and standard cost? The process which links the federal struc‐
ture of the nation with the screening is a thin red line which began with the promulgation of
the Constitution and over the years it has been fully implemented with Act No. 42 of year
2009 with enforcement of Article 119 of the Constitution which guarantees autonomy of rev‐
enues and expenditure of municipalities, provinces, towns and regions and assure princi‐
ples of support and social cohesion [32]. In particular, it assures the funding of the essential
levels of health care (which includes the practice of screening) referring to a benchmark of
cost and requirements [32]. In year 2001 an agreement was made between Government and
Regions for the guidelines about prevention, diagnosis and assistance in oncology, including
indications for the screenings, and the promulgation of Decree of the President of the Coun‐
cil of Ministry No. 26 of November 29th 2001, which defines the Essential Levels of Care
(LEA) including the plans of screening for the early diagnosis of colorectal, breast, cervix
cancers [33]. Within the 2001 financial budget (law N. 388, 2000) it was decided that target
population screening was free of charge [34]. In 2004 the Health Minister redistributed over‐
all € 7.000.000, a minimum of € 50.000 per region, for reducing the gaps in cancer screenings
and activating the CCS programme (€ 1.750.000 specifically for CCS). This agreement made
these plans to be a right for women and men. The debate about the allocation of resources in
regimen of federalism is very lively, in particular regarding the costs of Health Care System.
We remind that the allocation of the funds to the Health Care System for the prevention of
diseases remained constant at 5% for some years [35]. The criterion of the historical expendi‐
ture will be replaced by the standard cost. The standard cost is the tool to assure the LEA
funding and consists of the expenditure for the following items: staff, equipment, consuma‐
bles and general costs of the health performances of the production unit [36]. Moreover, a
“direct” cost of production is predicted, i.e. a percentage to cover the general functioning
costs of the equipment of the production unit [37]. The characteristics of the colorectal can‐
cers show a strong geographical variability: chronic trend, increase in the incidence and a
still too high mortality rate. The increase in the prevalence should be allotted partially to the
ageing of the population, but mostly to the diffusion and implementation of screening plans.
The cost of the screening campaign is defined by the following factors: first costs of tests,
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staff, confirmation procedure (selection of population at risk to reduce costs); second assess‐
ment of efficacy: sensitivity, specificity, productive value; third non-invasive method: it is
addressed to probably healthy subjects; latter possibility of intervention: the disease or con‐
dition to be diagnosed should be susceptible of therapy.
In the first years 2000 the Italian Government, in view of the severe unbalanced offer of
screening plans, established to allocate further financial resources (52 million euro between
2004 and 2006) for interventions promoting the re-balancing of the offer and the quality of
the screening plan of cervix and breast cancers and the diffusion of the screening of colorec‐
tal cancer [33]. Even though in year 2008 in oncology the plans of screening of colorectal can‐
cers had a significant increase exceeding the threshold of 50%, unfortunately they are not
always able to achieve acceptable levels of efficacy. According to “The screening plans in
Italy 2009”, the screening campaigns for colorectal cancers carried out in the last years,
showed some critical aspects: we observed a progressive increase in the compliance of the
first years versus a progressive stabilization or decrease in the compliance afterwards [20].
There are extremely strong differences between Northern, Central and Southern Italy. How‐
ever, the rate of detection of cancers by using faecal occult blood and endoscopy has always
been lower than the acceptable minimum.
In fact, many differences are reported in relation with the ratio between regional and per
capita income resulting into a three-speed Italy. This is mirrored also by the incidence of col‐
orectal cancer, which exhibits a different distribution where the highest rate is in the North‐
ern Italy and the minimum rate in the Southern Italy. According to the data of the National
Screening Observatory, they are spread not uniformly throughout the territory. According
to “The screening plans in Italy 2009”, the real extension of colorectal screening plans (faecal
occult blood plus endoscopy) for the macro-areas evidenced some critical aspects [20]. We
passed from 5% in 2004 to 12% in 2005, then to 30% in 2006, which stabilized at 37% in
2007/2008 as global Italian data. Even though there were significant differences with a posi‐
tive presence in the Northern Italy versus a delay in the Central Italy and an insufficient
presence in the Southern Italy, these data showed a similar annual tendency for each macro-
area. However, the rate of identification of cancers by using faecal occult blood and endos‐
copy has always been lower than the acceptable minimum. After an initial enthusiasm, we
observed a progressive decrease in the percentage of compliance with the plan in both mac‐
ro-areas. Regarding the emigration index, there are notable differences within the three mac‐
ro-areas, which influence the general index. The value shows that the regions of Northern
Italy have more attraction power versus the regions of Southern Italy, whereas the regions
of Central Italy have not particularly high emigration indices.
This latter parameter: the DRG index shows clear imbalances within all regions and there‐
fore it is not a useful element to discriminate the different macro-areas.
The lack of homogeneity on the territory, moreover, is still marked with evident consequen‐
ces on mortality and morbidity [38]. The implementation of federalism poses a question: if
these large differences already exist, will the situation be improved or will the disparity be‐
come even stronger? On April 29, 2010, the agreement between Government, Regions and
Autonomous Provinces of Trento and Bolzano was undersigned. According to this agree‐
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ment the regions are committed to implement by September 2010, the Regional Plan of Pre‐
vention to carry out the interventions established by the National Plan of Prevention: among
the macro-areas of interventions there are oncologic screening programs [39]. The critical
points are: complications of COL (40 programmes) with average perforation rate of 0.08%
(2,5% operative COL) and average bleeding rate of 0,55%; low coverage and delay in South‐
ern Italy; low compliance; overload on endoscopy facilities.
The critical limit to implement the screening campaigns of colorectal cancers is the allocation
of own resources to Regions and local bodies and the overcoming of the dichotomy between
legislative and administrative (on the territory) competences and derived finance (transfer
from Government to territory) [40]. Up to now the Government has been engaged in fund‐
ing screening campaigns, from now on the Regions will be in charge of it [41]. Unfortunately
since there is not yet an assessment of the costs of this procedure, the “promotion cam‐
paign”, so far implemented, is risking to be reduced [42].
The concept of standard cost versus the historical cost is playing a crucial role in the fiscal
federalism. The standard cost will contribute, in fact, to establish the “official” needs of each
local body and therefore the contingent equalizing transfer to which it will have the right to
in case of insufficient fiscal capacity [43].
Which approach should be used to calculate the standard costs of the federal finance?
There are two models among those currently used: micro-analytical (standard cost of each
supplied performance) and macro-analytical (standard cost of easily measurable variables:
demographic structure, epidemiological and social characteristics). The first approach is not
very consistent with the purposes of the federalist reform (valid only as control mean) while
the second model establishes a budget of expenditure resulting from merely political choices
and not from the real needs of the population. What is the solution? To calculate the neces‐
sary resources the fundamental element to refer to is the efficiency [44-46]. The efficiency
measures the economical employment of resources in the productive process. It is defined as
the ratio between performances (screening) and resources (budget) according to the formu‐
la: efficiency= output/input [47,48].
A better approach, but for some aspects much more complex, could be the one of DEA [49].
Farrell (1957) in his preliminary work “The measurement of productive efficiency” intro‐
duced not only the well-known allocation between technique and price or allocative efficien‐
cy, but he also proposed a key to measure the comparative efficiency of the productive units
which use various inputs to produce different outputs [50]. The efficiency of each unit
would be equal to the ratio between real and potential output [51]. More than two decades
after Charnes, Cooper and Rhodes (CCR), the idea of Farrell was developed and it was dem‐
onstrated that a linear mathematical program could be used to choose the most effective
productive unit. The method, known as Data Envelopment Analysis, has been extensively
used to measure the efficiency in many economical areas [52].
The analyses are non-parametric and its characteristic is that it can evaluate the relative effi‐
ciency of decisional units, and the like, through linear programming techniques without
specifying whether the relative importance of the different factors of production or that of
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the prices [53]. In this sense the results of non-parametric methods are objective, because
they do not require prior specifications. On the other hand, however, their disadvantage is
that they do not admit errors being deterministic methods; the results could be therefore in‐
fluenced. The relative efficiency of the responsibility centres is determined according to the
following formula:
max
u,v
h 0(u, v)=∑r ur yr0  /∑ vi xi0
Now the system of weights adopted strongly influences the efficiency, therefore through
an algorithm of Charnes,  Cooper and Rhodes (CCR),  we try to find the optimal system
of weights (among the proposed ones) in order to maximize the efficiency of the respon‐
sibility centre and the comparable ideal responsibility centre [54].  This suggests that the
standard cost  can be calculated in  two ways:  maximizing the numerator  and fixing the
denominator (output-oriented method – screening) or, vice versa, keeping the numerator
and minimizing the denominator (input-oriented method – prevention budget) [55].  The
difference  is  important  since  it  determines  the  form of  efficiency that  we are  assessing.
Output-effective  means there  is  no other  unit  that  develops a  larger  screening with the
same budget for the prevention [56].
A productive unit is called input-effective if there is no other unit able to obtain the same
screening using a lower budget (DMUs).
This methodology assesses the efficiency as the ratio between quality of the screening and
available budget. Some weights are obviously introduced to include demographic and
health characteristics of the Region. Now for each unit we can obtain the optimal budget to
be allocated to the Region for the screening campaign. In this way by adding the sum of ev‐
ery single regional budget, the necessary budget of national expenditure can be obtained to
carry out an effective and really sustainable screening campaign.
In view of the above mentioned results, we can assume an equivalent model (Table 4).
The following example of three Regions (large, middle, and small) illustrate how DEA
works.
Each Region has exactly 10 COL (the only input), and we are be able to measure a Region
CCR programme based on two outputs: number of patients subject to screening, and num‐
ber of found cancers. The data for these Regions is as follows:
Region “large”: 100 COL, 1000 number of recruited patients, 20 number of found cancers;
Region “medium”: 100 COL, 400 number of recruited patients, 50 number of found cancers;
Region “small”: 100 COL, 200 number of recruited patients, 150 number of found cancers.
Now, the key to DEA is to determine whether we can create a virtual Region that is better
than one or more of the real Regions. Any such dominated Region will be an inefficient Re‐
gion. Consider trying to create a virtual Region that is better than Region “large”. Such a Re‐
gion would use no more inputs than a Region “large”, and produce at least as much output.
Clearly, no combination of Regions “medium” and “small” can possibly do that. Region
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“large” is therefore deemed to be efficient. Region “small” is in the same situation. Howev‐
er, consider Region “medium”. If we take half of Region “large” and combine it with half of
Region “small”, then we create a Region that processes different outputs (600 number of re‐
cruited patients, 85 number of found cancers) with just input (100 COL). This dominates
“medium” (we would much rather have the virtual Region we created than Region “medi‐
um”). Region “medium” is therefore inefficient. Another way to see this is that we can scale
down the inputs to “medium” (number of COL) and still have at least as much output. If we
assume (and we do), that inputs are linearly scalable, then we estimate that we can get by
with 63 COL. We do that by taking 0.34 times Region “small” plus 0.29 times Region “medi‐
um”. The result uses 63 COL and produces at least as much as Region “medium” does. We
say that Region “medium”’s efficiency rating is 0.63. Regions “small” and “large” have an
efficiency rating of 1.
Region
Large Middle Small
Population size
Average
Range
Input
Equivalent number of hours of physicians of general medicine
Equivalent number of hours of endoscopists
Equivalent number of hours of anaesthetists
Equivalent number of hours of nurses
Equivalent number of hours of executives
Equivalent number of hours of lab physician
Number of evaluations
Number of endoscopies
Number of histological exams
Equivalent number of hours of pathologists
Equivalent number of hours of technicians of pathologic anatomy
Number of histological analyses
Output
Number of recruited patients
Number of patients subject to screening
Number of found cancers
Table 4. Example of sustainable screening campaign.
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After the definition of the population size and the observed input and output to assess the
screening unit (DMUs), it is possible to calculate the index of efficiency by using the above-
mentioned formula. This index can be referred to the single Regions or to the system Italy as
a whole.
In many states, a larger question may be whether the overwhelming use of COL as the
screening method is the appropriate choice.
Determination of the appropriateness of an indication for COL has been advanced as a
means to help rationalize the use of endoscopic resources. Current guidelines regarding the
appropriateness of COL are relatively inefficient in excluding a clinically meaningful CRC
risk for patients, in whom COL is generally not indicated, raising serious concerns about
their applicability to clinical practice.
A tailored navigation approach, which determines the particular concerns and barriers of an
eligible individual and matches them with the strengths and weaknesses of each strategy to
find the one most suitable, may be the optimal way to maximize the number of people who
can benefit from COL.
In the end, a test can only provide benefit if it is actually done [57].
5. Conclusions
Nowadays the Italian National Health Service is distributed on extremely diversified region‐
al realities. Needs and inefficiencies of production are inseparably correlated in the health
expenditure of the Regions. In the future the issues that are now more critical will have to be
adjusted: to implement screening plans, supply the Regions with the objectives related to
common LEAs in view of the regional differences. According to the “National Centre for the
Prevention and Control of the Diseases” (institution of coordination between Ministry of
Health and Regions for the activities of surveillance, prevention and prompt response to the
emergencies), it is necessary to “design the interventions of secondary prevention not as
performances but rather as “paths” (profiles of care) offered to the citizen within various or‐
ganizing activities on the territory aiming at the efficiency in the practice”. Only in this way
the efficiencies can be optimized and the necessary budget minimized for each Region for
the screening campaigns. In order to avoid the funding of squandering, a formula of analyti‐
cal calculation of the needs will be necessary [58]. A further problem in the future will be to
make homogeneous the different kinds of screening currently in use on the territory to as‐
sure a higher allocative efficiency and COL will clearly has a future, which will expand even
if the technology stands still. For a screening programme to be successful, multiple events
have to occur, beginning with awareness and recommendation from the primary-care physi‐
cian, patient acceptance, financial coverage, risk stratification, screening test, timely diagno‐
sis, timely treatment, and appropriate follow-up. If any one of these steps is faulty or is not
of high quality, the screening will fail. In this scenario we had to consider the COL as a
means than an aim. In this regard DEA, which is an innovative methodology easy to be ap‐
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plied especially in the health care with diversified systems as ours, can be a useful tool to
calculate the regional needs in order to carry out screening campaigns.
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